Lin J T, Wang J T, Wu M S, Huang S C, Wang T H
Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei.
Hepatogastroenterology. 1993 Dec;40(6):600-3.
The influence of Helicobacter pylori infection on serum levels of pepsinogen I and gastrin in gastric carcinoma was investigated by simultaneous determination of serum pepsinogen I, gastrin, and IgG antibodies against Helicobacter pylori in 100 patients with gastric carcinoma, and in another 100 age- and sex-matched healthy controls. Serum pepsinogen I level was significantly lower in gastric carcinoma than in controls (55.5 +/- 28.1 vs. 76.9 +/- 25.1 ng/ml, p < 0.005), but there was no difference in serum gastrin between them (63.2 +/- 30.2 vs. 57.4 +/- 28.5 pg/ml, p = 0.16). Helicobacter pylori infection caused a significant increase in serum PGI level in advanced, intestinal type, and non-cardia gastric carcinoma. The serum gastrin level was affected by neither Helicobacter pylori infection nor any of the tumor characteristics. It is concluded that pepsinogen I, rather than gastrin, in the serum is greatly influenced by Helicobacter pylori infection and tumor characteristics in gastric carcinoma.
通过同时测定100例胃癌患者以及另外100例年龄和性别匹配的健康对照者的血清胃蛋白酶原I、胃泌素和抗幽门螺杆菌IgG抗体,研究幽门螺杆菌感染对胃癌患者血清胃蛋白酶原I和胃泌素水平的影响。胃癌患者血清胃蛋白酶原I水平显著低于对照组(55.5±28.1 vs. 76.9±25.1 ng/ml,p<0.005),但两者血清胃泌素水平无差异(63.2±30.2 vs. 57.4±28.5 pg/ml,p = 0.16)。幽门螺杆菌感染导致进展期、肠型和非贲门部胃癌患者血清PGI水平显著升高。血清胃泌素水平既不受幽门螺杆菌感染影响,也不受任何肿瘤特征影响。得出结论,血清中的胃蛋白酶原I而非胃泌素受胃癌中幽门螺杆菌感染和肿瘤特征的影响很大。